Potency (pharmacology) explained

In pharmacology, potency or biological potency[1] is a measure of a drug's biological activity expressed in terms of the dose required to produce a pharmacological effect of given intensity.[2] A highly potent drug (e.g., fentanyl, clonazepam, risperidone, benperidol, bumetanide) evokes a given response at low concentrations, while a drug of lower potency (e.g. morphine, alprazolam, ziprasidone, haloperidol, furosemide) evokes the same response only at higher concentrations. Higher potency does not necessarily mean greater effectiveness nor more side effects nor less side effects.

Types of potency

The International Union of Basic and Clinical Pharmacology (IUPHAR) has stated that "potency is an imprecise term that should always be further defined", and lists of types of potency as follows:

Type of potency SymbolDefinition
Effective doseED_It is the minimum dose or concentration of a drug that produces a biological response in 50% of a population being studied.
Median lethal doseLD_For either drugs or toxins, it is a toxic unit that measures the minimum dose that causes death (lethal dose) in 50% of cases.
Median toxic doseTD_It is the minimum dose at which toxicity occurs in 50% of cases.
Half maximal effective concentrationEC_It is a measure of the concentration of a drug, antibody or toxicant which induces a biological response halfway between the baseline and maximum after a specified exposure time.
In other words, it can be defined as the concentration required to obtain a 50% effect.[3]
Half maximal inhibitory concentrationIC_It is a measure of the potency of a substance in inhibiting a specific biological or biochemical function.

See also

Further reading

https://www.addictioncenter.com/news/2019/08/15-most-dangerous-drugs/https://nida.nih.gov/research-topics/commonly-used-drugs-charts#top

Notes and References

  1. MILES AA, PERRY EL. Biological potency and its relation to therapeutic efficacy. Bull World Health Organ. 1953;9(1):1-14. PMID: 13082386; PMCID: PMC2542104.
  2. Neubig RR, Spedding M, Kenakin T, Christopoulos A . International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology . Pharmacological Reviews . 55 . 4 . 597–606 . December 2003 . 14657418 . 10.1124/pr.55.4.4 . 1729572.
  3. Web site: Introducing dose response curves . https://web.archive.org/web/20120730150339/http://www.graphpad.com/curvefit/introduction89.htm . 2012-07-30 . Graphpad Software.